This paper reviews the clinical manifestations of acute and chronic sarcoidosis. The indications for measuring serum angiotensin converting enzyme and for performing pulmonary function tests, bronchiolo-alveolar lavage and gallium scans are discussed and the modern indications for performing a Kveim Siltzbach test are also considered. The main treatment available for patients with sarcoidosis is systemic steroids and the indications in the various systems for using these drugs are discussed.
Introduction
Sarcoidosis occurs in 19 out of every 100,000 white people in the United Kingdom. However, in areas of high immigrant population this figure may be increased, as the prevalence of the condition in West Indian immigrants is 40 per 100,000, whilst in the Irish living in London the figure has been reported to be as high as 160 per 100,000.1 Asian immigrants are less commonly affected, but sarcoidosis is being increasingly found in this group as well, though figures are not available for the prevalence. Indeed, the above quoted figures date from the days when mass radiography was available in the United Kingdom and may no longer be valid. Sarcoidosis most commonly presents between the age of 20 and 40 years, though any age may be affected. There is no predilection for either sex, but most reported series include a slightly higher number of female patients.
Acute sarcoidosis
As recently as 1946, L6fgren2 drew attention to the syndrome of erythema nodosum, arthralgia, bilateral hilar lymphadenopathy and occasionally acute anterior uveitis. Prior to this, sarcoidosis had been considered a chronic disabling condition, but Lofgren was able to identify this clinical entity as a form of sarcoidosis and establish its good prognosis.
Erythema nodosum
This skin rash presents acutely with red. tender spots on the shins which gradually fade to bruises. 
